Free Trial
NYSE:ARDT

Ardent Health (ARDT) Stock Price, News & Analysis

Ardent Health logo
$14.66 +0.07 (+0.49%)
Closing price 10/17/2025 03:59 PM Eastern
Extended Trading
$14.46 -0.20 (-1.36%)
As of 10/17/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ardent Health Stock (NYSE:ARDT)

Advanced

Key Stats

Today's Range
$14.32
$14.79
50-Day Range
$12.04
$14.66
52-Week Range
$10.10
$19.94
Volume
322,885 shs
Average Volume
436,734 shs
Market Capitalization
$2.10 billion
P/E Ratio
8.10
Dividend Yield
N/A
Price Target
$19.30
Consensus Rating
Moderate Buy

Company Overview

Ardent Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

ARDT MarketRank™: 

Ardent Health scored higher than 73% of companies evaluated by MarketBeat, and ranked 268th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ardent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.54, and is based on 9 buy ratings, 2 hold ratings, and 2 sell ratings.

  • Upside Potential

    Ardent Health has a consensus price target of $19.30, representing about 31.6% upside from its current price of $14.66.

  • Amount of Analyst Coverage

    Ardent Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Ardent Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Ardent Health are expected to grow by 59.35% in the coming year, from $1.23 to $1.96 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ardent Health is 8.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 230.70.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ardent Health is 8.10, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 84.52.

  • Price to Earnings Growth Ratio

    Ardent Health has a PEG Ratio of 6.45. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Ardent Health has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Ardent Health's valuation and earnings.
  • Percentage of Shares Shorted

    7.50% of the float of Ardent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardent Health has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Ardent Health has recently increased by 19.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Ardent Health does not currently pay a dividend.

  • Dividend Growth

    Ardent Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    7.50% of the float of Ardent Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Ardent Health has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in Ardent Health has recently increased by 19.61%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Ardent Health has a news sentiment score of 0.85. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.46 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Ardent Health this week, compared to 4 articles on an average week.
  • Search Interest

    4 people have searched for ARDT on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Ardent Health to their MarketBeat watchlist in the last 30 days.
Receive ARDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ardent Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARDT Stock News Headlines

Brokerages Set Ardent Health, Inc. (NYSE:ARDT) Price Target at $19.33
Buy UBER immediately
BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on some of the biggest winners of 2025.tc pixel
Ardent Health, Inc. (NYSE:ARDT) Receives $19.33 Consensus PT from Analysts
See More Headlines

ARDT Stock Analysis - Frequently Asked Questions

Ardent Health's stock was trading at $17.08 at the beginning of 2025. Since then, ARDT stock has decreased by 14.2% and is now trading at $14.6610.

Ardent Health, Inc. (NYSE:ARDT) announced its quarterly earnings results on Tuesday, August, 5th. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.22. The firm had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a net margin of 4.11% and a trailing twelve-month return on equity of 16.66%.
Read the conference call transcript
.

Ardent Health (ARDT) raised $192 million in an initial public offering (IPO) on Thursday, July 18th 2024. The company issued 12,000,000 shares at $16.00 per share.

Ardent Health's top institutional shareholders include Wedge Capital Management L L P NC (0.08%), Voya Investment Management LLC (0.03%) and CWM LLC (0.01%).

Shares of ARDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ardent Health investors own include Broadcom (AVGO), 4D Molecular Therapeutics (FDMT), Mirum Pharmaceuticals (MIRM), Micron Technology (MU), Uber Technologies (UBER), Advanced Micro Devices (AMD) and ASML (ASML).

Company Calendar

Last Earnings
8/05/2025
Today
10/18/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:ARDT
Previous Symbol
NYSE:ARDT
CIK
1756655
Web
N/A
Fax
N/A
Employees
24,900
Year Founded
2001

Price Target and Rating

High Price Target
$25.00
Low Price Target
$14.60
Potential Upside/Downside
+31.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.54
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.81
Trailing P/E Ratio
8.10
Forward P/E Ratio
11.92
P/E Growth
6.45
Net Income
$210.34 million
Net Margins
4.11%
Pretax Margin
6.78%
Return on Equity
16.66%
Return on Assets
5.18%

Debt

Debt-to-Equity Ratio
0.66
Current Ratio
2.13
Quick Ratio
2.00

Sales & Book Value

Annual Sales
$5.97 billion
Price / Sales
0.35
Cash Flow
$2.55 per share
Price / Cash Flow
5.75
Book Value
$10.66 per share
Price / Book
1.38

Miscellaneous

Outstanding Shares
143,110,000
Free Float
140,673,000
Market Cap
$2.10 billion
Optionable
Optionable
Beta
0.39

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:ARDT) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners